Clinical Portfolio 2014—2026
Twelve years of interventional cardiology. A research-led practice where every patient is a study and every study informs the next procedure.
Dr. Mila Reinhardt completed her cardiology residency at Charité — Universitätsmedizin Berlin in 2014, followed by an interventional fellowship at the German Heart Center Munich. Her clinical practice focuses on complex coronary interventions, structural heart disease, and the long-term outcomes of patients with chronic conditions.
She leads the Reinhardt Research Group, an independent practice that runs prospective cohort studies alongside routine care. Patients receive treatments informed by the latest evidence — and contribute to the evidence that shapes the next generation of treatments.
Each focus is supported by an active registry and reviewed annually against international outcomes data. The result is a practice that adapts with the evidence rather than against it.
Complex coronary angioplasty, chronic total occlusions, and high-risk percutaneous interventions.
Transcatheter valve procedures, left atrial appendage closure, and adult congenital interventions.
Long-term management programs for reduced ejection fraction, advanced therapies, and device follow-up.
Prospective cohort studies, device registries, and outcome-driven protocol design.
Anonymised with patient consent. Each entry includes the diagnostic question, the intervention chosen, and the measured outcome at 12 months.
OR · Berlin Twelve-month-old CTO with poor distal runoff. Retrograde approach via septal collaterals. Final TIMI 3 flow achieved with two drug-eluting stents. At 12 months: no restenosis, LVEF improved from 38% to 51%, return to full activity.
Cath Lab Transfemoral TAVI with conscious sedation. Predilation avoided due to annular calcification. Post-dilation balloon valvuloplasty at 6 months for paravalvular leak. NYHA class improved from III to I within 30 days.
Studio · Berlin HAS-BLED 4. Recurrent GI bleeding on anticoagulation. Watchman FLX implanted under TEE guidance. Anticoagulation discontinued at 45 days. No bleeding or thromboembolic events at 24-month follow-up.
Dr. Reinhardt explained every option with the same rigour she brings to her research papers. Twelve months after the procedure I am back to cycling 80 kilometres on weekends.
Mila is the rare clinician who combines technical excellence with methodological discipline. Her registry data is among the cleanest in the field, and we cite it often.
After three cardiologists told me my case was inoperable, Dr. Reinhardt reviewed my records in detail and proposed a plan. The procedure took four hours and the result changed my life.
Working with the Reinhardt Research Group on the RECOVER-CTO protocol taught our team an entirely new standard for prospective data collection.
Studio · Berlin Mitte Initial consultations are scheduled for 45 minutes and include a review of prior records. Referrals from general practitioners are welcome, and self-referrals are accepted for complex cases.